The drugmaker settled a patent infringement lawsuit from Endo Pharmaceuticals (NMS:ENDP) and will sell a generic version of Endo's Opana ER painkilling pill in Sept. 2012, a year before patents on the drug start to expire. Watson Pharmaceuticals (NYSE:WPI - News) is getting a royalty-free license to Opana patents. Endo's combined sales of the pill and its injectable version totaled $230.6 mil in 2009. Watson edged up 0.4% to 44.42. Endo gained 4 cents to 34.18.
Affluent Americans may want to double-check how much of their bank deposits are protected by government-backed insurance. The rules governing trust accounts just changed.
The 2024 Yankees have rediscovered their bravado and hold the second-best record in the AL, thanks in large part to the superstar outfielder.
Murray made a bad night on the court worse during a moment of frustration on the bench.
Frank Vogel's out after one season in Phoenix failed to produce a playoff win.
Former NBA guard Darius Morris has died at the age of 33. He played for five teams during his four NBA seasons. Morris played college basketball at Michigan.
The Yahoo Fantasy football crew got together for their very first mock draft of 2024. Andy Behrens recaps the results.
Jason Fitz, Charles Robinson and Frank Schwab talk about which quarterback rooms concern them and which they find interesting heading into the 2024 NFL season.
Teams have made their big splashes in free agency and made their draft picks, it's time for you to do the same. It's fantasy football mock draft time. Some call this time of year best ball season, others know it's an opportunity to get a leg up on your competition for when you have to draft in August. The staff at Yahoo Fantasy did their first mock draft of the 2024 season to help you with the latter. Matt Harmon and Andy Behrens are here to break it all down by each round and crush some staff members in the process.
The value of the Dolphins and Formula One racing is enormous.
Ryan says he would be writing in a Republican candidate instead of voting for Donald Trump.
It’s key to note that we’re not saying the “best team” or “best roster.” Instead, we’re talking about the best confluence of factors that can outline a path for survival and then success.
With free agency and the draft behind us, what 32 teams look like today will likely be what they look like Week 1 and beyond for the 2024 season. Matt Harmon and Scott Pianowski reveal the post-draft fantasy power rankings. The duo break down the rankings in six tiers: Elite offensive ecosystems, teams on the cusp of being complete mixed bag ecosystems, offensive ecosystems with something to prove, offenses that could go either way, and offenses that are best to stay away from in fantasy.
The Cardinals' nightmare season continues.
Jake Mintz & Jordan Shusterman discuss the Padres-Marlins trade that sent Luis Arraez to San Diego, as well as recap all the action from this weekend in baseball and send birthday wishes to hall-of-famer Willie Mays.
The energy transition will benefit companies providing electrical needs for surging demand. Analysts point to these three stocks as a Buy.
Dan Devine and Adam Mares discuss the Denver Nuggets and Minnesota Timberwolves after Monday night’s game 2.
Fantasy baseball analyst Fred Zinkie offers up his top buy low/high and sell low-high candidates for Week 6.
Fantasy baseball analyst Fred Zinkie offers up his blueprint for conquering the final days of Week 6.
In the most anticlimactic way possible, Nintendo on Tuesday confirmed years of rumors: The Nintendo Switch 2 console is on the way. "We will make an announcement about the successor to Nintendo Switch within this fiscal year," wrote Shuntaro Furukawa, the president of Nintendo, on X. Rather, Furukawa wanted to warn users not to expect the actual announcement in next month's Nintendo Direct livestream.
The Utilities and Consumer Staples sectors have popped since mid-April as investors search for value.